Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Parkhurst

Showing results (91-100 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Pathology Oncology Research : POR|October 29, 2017
Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy AloneSteven N Seyedin, Darrion L Mitchell, Sarah L Mott, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Human Gene Therapy|July 29, 2010
Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cellsSteven A Feldman, Stephanie L Goff, Hui Xu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 21, 2020
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single CellsBiman C Paria, Noam Levin, Frank J Lowery, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.
Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Pageof 13

Showing results (91-100 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Experimental Medicine|July 22, 1998
gp100/pmel 17 is a murine tumor rejection antigen: induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligandW W Overwijk, A Tsung, K R Irvine, et al.
Pathology Oncology Research : POR|October 29, 2017
Is More Always Better? An Assessment of the Impact of Lymph Node Yield on Outcome for Clinically Localized Prostate Cancer with Low/Intermediate Risk Pathology (pT2-3a/pN0) Managed with Prostatectomy AloneSteven N Seyedin, Darrion L Mitchell, Sarah L Mott, et al.
Science (New York, N.Y.)|May 10, 2014
Cancer immunotherapy based on mutation-specific CD4+ T cells in a patient with epithelial cancerEric Tran, Simon Turcotte, Alena Gros, et al.
Human Gene Therapy|July 29, 2010
Rapid production of clinical-grade gammaretroviral vectors in expanded surface roller bottles using a "modified" step-filtration process for clearance of packaging cellsSteven A Feldman, Stephanie L Goff, Hui Xu, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|October 21, 2020
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single CellsBiman C Paria, Noam Levin, Frank J Lowery, et al.
Cancer Research|June 11, 1999
Recombinant virus vaccination against "self" antigens using anchor-fixed immunogensK R Irvine, M R Parkhurst, E P Shulman, et al.
Cancer Immunology Research|June 30, 2016
Tumor- and Neoantigen-Reactive T-cell Receptors Can Be Identified Based on Their Frequency in Fresh TumorAnna Pasetto, Alena Gros, Paul F Robbins, et al.
Cancer Immunology Research|June 18, 2016
Durable Complete Response from Metastatic Melanoma after Transfer of Autologous T Cells Recognizing 10 Mutated Tumor AntigensTodd D Prickett, Jessica S Crystal, Cyrille J Cohen, et al.
Nature Medicine|February 23, 2016
Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patientsAlena Gros, Maria R Parkhurst, Eric Tran, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 7, 2014
A novel murine T-cell receptor targeting NY-ESO-1Shannon F Rosati, Maria R Parkhurst, Young Hong, et al.
Pageof 13